Connect® Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
Arms / Cohorts
Observational:Newly diagnosed Lower-Risk Myelodysplastic Syndromes (LR-MDS)
Accepting patients
Observational:Newly diagnosed Higher-Risk Myelodysplastic Syndromes (HR-MDS)
Accepting patients
Observational:Newly diagnosed Acute Myeloid Leukemia (AML)
Accepting patients
Observational:Newly diagnosed Idiopathic cytopenia of undetermined significance (ICUS)
Accepting patients
Observational:Treated Lower-Risk Myelodysplastic Syndromes (LR-MDS)
Accepting patients
Observational:Luspatercept Treated Cohort (LTC)
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.